Improving Transparency and Accuracy in Medicare Part D Spending Act
USA116th CongressHR-803| House
| Updated: 3/1/2019
Peter Welch
Democratic Representative
Vermont
Cosponsors (28)
Mo Brooks (Republican)Roger Marshall (Republican)Jared F. Golden (Democratic)Eric A. "Rick" Crawford (Republican)Martha Roby (Republican)Steve Womack (Republican)Rick W. Allen (Republican)Doug Collins (Republican)John P. Sarbanes (Democratic)Earl L. "Buddy" Carter (Republican)Vicente Gonzalez (Democratic)Thomas Massie (Republican)J. French Hill (Republican)H. Morgan Griffith (Republican)G. K. Butterfield (Democratic)Mike D. Rogers (Republican)John Joyce (Republican)Ron Estes (Republican)Jamie Raskin (Democratic)Cynthia Axne (Democratic)Bradley Byrne (Republican)Robert E. Latta (Republican)Tom Graves (Republican)Cathy McMorris Rodgers (Republican)Jaime Herrera Beutler (Republican)Lloyd Doggett (Democratic)David P. Roe (Republican)Chellie Pingree (Democratic)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Improving Transparency and Accuracy in Medicare Part D Spending Act This bill prohibits Medicare prescription drug plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. (A "clean claim" is a Medicare claim that is free of defects such as incomplete documentation.)
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Health
MedicarePrescription drugs
Improving Transparency and Accuracy in Medicare Part D Spending Act
USA116th CongressHR-803| House
| Updated: 3/1/2019
Improving Transparency and Accuracy in Medicare Part D Spending Act This bill prohibits Medicare prescription drug plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. (A "clean claim" is a Medicare claim that is free of defects such as incomplete documentation.)
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Peter Welch
Democratic Representative
Vermont
Cosponsors (28)
Mo Brooks (Republican)Roger Marshall (Republican)Jared F. Golden (Democratic)Eric A. "Rick" Crawford (Republican)Martha Roby (Republican)Steve Womack (Republican)Rick W. Allen (Republican)Doug Collins (Republican)John P. Sarbanes (Democratic)Earl L. "Buddy" Carter (Republican)Vicente Gonzalez (Democratic)Thomas Massie (Republican)J. French Hill (Republican)H. Morgan Griffith (Republican)G. K. Butterfield (Democratic)Mike D. Rogers (Republican)John Joyce (Republican)Ron Estes (Republican)Jamie Raskin (Democratic)Cynthia Axne (Democratic)Bradley Byrne (Republican)Robert E. Latta (Republican)Tom Graves (Republican)Cathy McMorris Rodgers (Republican)Jaime Herrera Beutler (Republican)Lloyd Doggett (Democratic)David P. Roe (Republican)Chellie Pingree (Democratic)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
MedicarePrescription drugs